0Suppliers
5Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Benitec Biopharma Inc. (BNTC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships
2Distinct source URLs
3High confidence
0.750Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Benitec Biopharma Inc. Suppliers

No suppliers on recordBenitec Biopharma Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.

Benitec Biopharma Inc. Customers

TickerNameConfidenceEvidence
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from BNTC graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BNTC graph: Reciprocal relationship from MYGN g…
MYGN Myriad Genetics, Inc. 72% vestigators, CROs, consultants and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and insider trading. We are exposed to the risk of …
AUSTRALIA-BENITEC-AUSTRALIA-PROPRIETARY-LIMITED- AUSTRALIA-BENITEC-AUSTRALIA-PROPRIETARY-LIMITED- 62% 4,464 Liabilities and Stockholders’ Equity Current liabilities: Trade and other payables $ 4,165 $ 3,231 Accrued employee benefits 475 472 Lease liabilities, current portion 284 275 Total current lia…
LIFE-TECHNOLOGIES-CORP LIFE-TECHNOLOGIES-CORP 62% vestigators, CROs, consultants and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and insider trading. We are exposed to the risk of …
PROPRIETARY-LIMITED PROPRIETARY-LIMITED 62% 4,464 Liabilities and Stockholders’ Equity Current liabilities: Trade and other payables $ 4,165 $ 3,231 Accrued employee benefits 475 472 Lease liabilities, current portion 284 275 Total current lia…

Benitec Biopharma Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BNTC-DEBT Debt stack $876,000 90% Market cache reports total debt of $876,000.
BNTC-DEBT-8312 Warrants outstanding: 2584239 90% xbrl warrant detail from xbrl 2024-04-22.

Benitec Biopharma Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Benitec Biopharma Inc..

Benitec Biopharma Inc. Ownership

HolderNameConfidenceEvidence
BNTC-OWNER-SUVRETTA-CAPITAL-MANAGEMENT-LLC SUVRETTA CAPITAL MANAGEMENT, LLC 90% 13F overlay lists SUVRETTA CAPITAL MANAGEMENT, LLC as top holder; 88 tracked holders.

Benitec Biopharma Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JANX Janux Therapeutics, Inc. 100.00 2
TEM Tempus AI, Inc. 100.00 2
DNLI Denali Therapeutics Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
IRD Opus Genetics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
KDK Kodiak AI, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CABA Cabaletta Bio, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
ATYR aTyr Pharma, Inc. 100.00 2
BIAF bioAffinity Technologies, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
HOWL Werewolf Therapeutics, Inc. 100.00 2
GH Guardant Health, Inc. 100.00 2
MYGN Myriad Genetics, Inc. 100.00 1 ['customer']
🔐
BNTC
Unlock BNTC Supply Chain Data
Verified relationships include:
MYGNMyriad Genetics, Inc.Customer72%
MYGNMyriad Genetics, Inc.Customer72%
+4 more relationships locked
Subscribe, View plans →